BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Lung cancer
,
Endothelial cell
,
Pharmacogenetics
,
Cisplatin
,
KLK3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CYBA;jsessionid=047D3B7814542ACA521CDABCAE4CB626
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Whole blood
Bone marrow
Tonsil
Lung
Fetal lung
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Recombinant form of mammalian gp91(phox) is active in the absence of p22(phox).
Identification of NOX2 regions for normal biosynthesis of cytochrome b558 in phagocytes highlighting…
Characterization of missense mutations in the NADPH oxidase partner p22phox in the A22° subtype of c…
Regulation of Derlin-1-mediated degradation of NADPH oxidase partner p22phox by thiol modification.
Inhibition of p22phox Suppresses Epithelial Ovarian Cancer Cell Proliferation and Tumorigenesis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for CYBA;jsessionid=047D3B7814542ACA521CDABCAE4CB626
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ